420 related articles for article (PubMed ID: 26014047)
21. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
23. Intrathecal IgM synthesis as a diagnostic marker in patients with suspected CNS lymphoma.
Reinecke R; Jahnke K; Foltyn-Dumitru M; Lachner K; Armbrust M; Weber KJ; Zeiner PS; Czabanka M; Brunnberg U; Hartmann S; Steinbach JP; Ronellenfitsch MW
J Neurochem; 2024 Jun; 168(6):1157-1167. PubMed ID: 38332527
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
[TBL] [Abstract][Full Text] [Related]
25. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
26. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
[TBL] [Abstract][Full Text] [Related]
27. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
[No Abstract] [Full Text] [Related]
28. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
Pittman M; Treese S; Chen L; Frater JL; Nguyen TT; Hassan A; Kreisel F
Arch Pathol Lab Med; 2013 Nov; 137(11):1610-8. PubMed ID: 24168498
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
[TBL] [Abstract][Full Text] [Related]
30. Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children.
Millner MM; Franthal W; Thalhammer GH; Berghold A; Aigner RM; Füger GF; Reibnegger G
Clin Chem; 1998 Jan; 44(1):161-7. PubMed ID: 9550574
[TBL] [Abstract][Full Text] [Related]
31. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
van Westrhenen A; Smidt LCA; Seute T; Nierkens S; Stork ACJ; Minnema MC; Snijders TJ
Br J Haematol; 2018 Aug; 182(3):384-403. PubMed ID: 29808930
[TBL] [Abstract][Full Text] [Related]
33. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
[TBL] [Abstract][Full Text] [Related]
34. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
36. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.
Mao X; Sun Y; Tang J
Neurol Sci; 2014 Feb; 35(2):233-8. PubMed ID: 23832112
[TBL] [Abstract][Full Text] [Related]
37. [Investigation of diagnosis and treatment for primary central nervous system lymphoma].
Meng FG; Zhang K; Mao GS; Wang ZC; Wu CY; Liu K
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1549-52. PubMed ID: 18282393
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Sasagawa Y; Akai T; Tachibana O; Iizuka H
J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
[TBL] [Abstract][Full Text] [Related]
39. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma.
Antinori A; De Rossi G; Ammassari A; Cingolani A; Murri R; Di Giuda D; De Luca A; Pierconti F; Tartaglione T; Scerrati M; Larocca LM; Ortona L
J Clin Oncol; 1999 Feb; 17(2):554-60. PubMed ID: 10080599
[TBL] [Abstract][Full Text] [Related]
40. Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.
Cordone I; Masi S; Carosi M; Vidiri A; Marchesi F; Marino M; Telera S; Pasquale A; Mengarelli A; Conti L; Pescarmona E; Pace A; Carapella CM
J Exp Clin Cancer Res; 2016 Aug; 35(1):128. PubMed ID: 27567676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
